Jeongsil Kim‐Ha

Tumor subtype-specific transcriptional signatures predict recurrence risk in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) displays significant molecular heterogeneity that clinical staging alone does not fully account for when assessing the risk of recurrence following curative treatment. To address this, we developed a multi-cohort survival modeling framework that tra...